WallStreetZenWallStreetZen

NASDAQ: GMAB
Genmab A Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GMAB

Based on 4 analysts offering 12 month price targets for Genmab A.
Min Forecast
$32.00+1.23%
Avg Forecast
$45.25+43.15%
Max Forecast
$54.00+70.83%

Should I buy or sell GMAB stock?

Based on 4 analysts offering ratings for Genmab A.
Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their GMAB stock forecasts and price targets.

GMAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-28
lockedlocked$00.00+00.00%2023-11-09
lockedlocked$00.00+00.00%2023-10-13
lockedlocked$00.00+00.00%2023-09-26

1 of 1

Forecast return on equity

Is GMAB forecast to generate an efficient return?
Company
N/A
Industry
-0.68%
Market
30.08%

Forecast return on assets

Is GMAB forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.19%

GMAB revenue forecast

What is GMAB's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$2.4B-1.92%
Avg 2 year Forecast
$2.7B+11.66%
Avg 3 year Forecast
$3.2B+33.17%
GMAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GMAB earnings growth forecast

How is GMAB forecast to perform vs Biotechnology companies and vs the US market?
Company
34.93%
Industry
8.12%
Market
17.67%
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GMAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GMAB revenue growth forecast

How is GMAB forecast to perform vs Biotechnology companies and vs the US market?
Company
9.42%
Industry
33.88%
Market
7.51%
GMAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GMAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GMAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GMAB$31.61$45.25+43.15%Buy
ALNY$168.25$234.30+39.26%Buy
BGNE$186.94$274.33+46.75%Strong Buy
BNTX$100.41$142.75+42.17%Strong Buy
BMRN$91.08$111.11+21.99%Buy
View Top Biotech Stocks

Genmab A Stock Forecast FAQ

Is Genmab A Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: GMAB) stock is to Buy GMAB stock.

Out of 4 analysts, 2 (50%) are recommending GMAB as a Strong Buy, 1 (25%) are recommending GMAB as a Buy, 0 (0%) are recommending GMAB as a Hold, 0 (0%) are recommending GMAB as a Sell, and 1 (25%) are recommending GMAB as a Strong Sell.

If you're new to stock investing, here's how to buy Genmab A stock.

What is GMAB's revenue growth forecast for 2023-2025?

(NASDAQ: GMAB) Genmab A's forecast annual revenue growth rate of 9.42% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.88%, and while it is forecast to beat the US market's average forecast revenue growth rate of 7.51%.

Genmab A's revenue in 2023 is $2,421,479,374.On average, 5 Wall Street analysts forecast GMAB's revenue for 2023 to be $156,461,537,044, with the lowest GMAB revenue forecast at $155,045,182,386, and the highest GMAB revenue forecast at $158,465,495,878. On average, 6 Wall Street analysts forecast GMAB's revenue for 2024 to be $178,125,196,199, with the lowest GMAB revenue forecast at $173,795,133,494, and the highest GMAB revenue forecast at $187,636,931,438.

In 2025, GMAB is forecast to generate $212,438,003,131 in revenue, with the lowest revenue forecast at $197,994,330,435 and the highest revenue forecast at $223,701,847,967.

What is GMAB's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GMAB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.19%.

What is GMAB's Price Target?

According to 4 Wall Street analysts that have issued a 1 year GMAB price target, the average GMAB price target is $45.25, with the highest GMAB stock price forecast at $54.00 and the lowest GMAB stock price forecast at $32.00.

On average, Wall Street analysts predict that Genmab A's share price could reach $45.25 by Nov 28, 2024. The average Genmab A stock price prediction forecasts a potential upside of 43.15% from the current GMAB share price of $31.61.

What is GMAB's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GMAB) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.